• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number VMFE131023
Device Problems Display or Visual Feedback Problem (1184); Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 02/27/2024
Event Type  Injury  
Event Description
It has been reported that a versacross connect access solution was selected for use.A perforation, a pericardial effusion (pe) and cardiac tamponade occurred, and the procedure was cancelled.During watchman procedure, right femoral access was achieved.The transesophageal echocardiography (tee) showed a trace pe and no clotting in the appendage.Baseline measurements were performed, and heparin was given.The watchman sheath and the versacross dilator were advanced over the versacross rf wire into the superior vena cava (svc).Using tee, a safe inferior and mid transseptal crossing was successfully achieved (no issues noted).The system was then advanced into the left atrium.When the dilator was being removed from the sheath, the rf wire accidentally also got pulled back into the sheath.When the physician was attempting to advance the rf wire back through, they experienced resistance.At this point, tee was unable to visualize the device, and so fluoroscopy was used.Suddenly, the patient's blood pressure began dropping to 50/38 and a pe was noted behind the right and left ventricle.Protamine was given and a pericardiocentesis was performed, removing roughly 750ccs of blood from the body.The patient was then stabilized and a cardiac care unit (ccu) bed was ordered.The patient was successfully discharged from the facility on (b)(6) 2024.The device is not expected to be returned for analysis.In the physician's opinion, the versacross device contributed to the complications.After transseptal, the physician accidentally removed the versacross rf wire with the dilator, upon reinsertion of the rf wire, resistance was felt.The pe grew significantly throughout the procedure but returned to baseline at the end.Patient was not on warfarin or antiplatelet drugs at the time of procedure.There is no reason to believe that the versacross dilator malfunctioned during the procedure.They also confirmed that a full dose of heparin was given prior to transseptal and act was therapeutic during the procedure.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18951281
MDR Text Key338259606
Report Number2124215-2024-16588
Device Sequence Number1
Product Code DXF
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150709
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot NumberVMFE131023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/16/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age80 YR
Patient SexMale
Patient Weight98 KG
Patient RaceWhite
-
-